Questionnaire-based analysis of the current level of asthma control and management in Niigata Prefecture, Japan: Changes from 1998 to 2000

Allergology International

Volumn 53, Issue 2, 2004, Pages 145-151

  Hasegawa, Takashi ^a,b   Suzuki, Eiichi ^a   Muramatsu, Yoshiyuki ^c   Koya, Toshiyuki ^b   Mashima, Ichiro ^b   Kondåoh, Ariyoshi ^a   Takagi, Hirofumi ^c   Fujimori, Katsuya ^d   Arakawa, Masaaki ^a   Yoshizawa, Hirohisa ^b   Gejyo, Fumitake ^a  

^a Niigata Asthma Treatment Study Group   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d Department of Pediatrics   (Japan)

Author keywords

Bronchial asthma; Inhaled steroid; Questionnaire; Satisfaction in daily life; Theophylline

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; DAILY LIFE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; JAPAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; SLEEP DISORDER; SYMPTOMATOLOGY;

EID: 3142552442     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1592.2004.00311.x     Document Type: Article

References (19)

1. Mattoli S, Mattoso VL, Solaperta M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J. Allergy Clin. Immunol. 1991; 87: 794-802.
2. Bentley AM, Menz G, Storz C et al. Identication of T lymphocytes, macrophages, and activated eosinaphils in the bronchial mucosa in intrinsic asthma. Am. Rev. Respir. Dis. 1992; 146: 500-6.
3. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 1989; 139: 242-6.
4. Djulanovic R. Airway inflammation and repair in asthma. Allergol. Int. 2001; 50: 281-94.
5. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 1996; 153: 1481-8.
6. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002. Bethesda: National Institutes of Health. 2002.
7. Makino S, Furusho K, Miyamoto T, Ohta K. Asthma Prevention and Management Guidelines 1998, Japan (JGL): English version. Int. Arch. Allergy Immunol. 2000; 121: 1-78.
8. Sly RM, O'Donnell R. Stabilization of asthma mortality. Ann. Allergy Asthma Immunol. 1997; 78: 347-54.
9. Scheffer AL. Death due to asthma. Allergol. Int. 1996; 45: 67.
10. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study. Eur. Respir. J. 2000; 16: 802-7.
11. Makina S. Present status of asthma management in Japan. Allergol. Int. 2001; 50: 5-14.
12. SPSS. SPSS for Windows-Based System User's Guide. Chicago: SPSS. 1992.
13. Reed CE, Offord KP, Nelson HS, Li JT, Tinkelman DG. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate Theophylline Study Group. J. Allergy Clin. Immunol. 1998; 101: 14-23.
14. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N. Engl. J. Med. 1997; 337: 1412-18.
15. Ukena D, Harnest U, Sakalauskas R et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur. Respir. J. 1997; 10: 2754-60.
16. McFadden ER, Casale TB, Edwards TB et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. J. Allergy Clin. Immunol. 1999; 104: 46-52.
17. Noonan MJ, Chervinsky P, Brandon M et al. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. Eur. Respir. J. 1998; 11: 1232-9.
18. Nagata S, Irie M, Mishima N. Stress and asthma. Allergol. Int. 1999; 48: 231-8.
19. Muramatsu K, Muramatsu Y, Fuse K et al. The amplification of somatic symptoms in upper respiratory tract infections. Gen. Hosp. Psychiatry 2002; 24: 172-5.